Pharmacokinetics of high-dose weekly ambisome (liposomal amphotericin B) antifungal prophylaxis in pediatric bone marrow transplantation (BMT) patients

被引：3
|
作者：
Mehta, PA [1 ]
Vinks, AA [1 ]
Filipovich, AH [1 ]
Vaughn, GA [1 ]
Fearing, DN [1 ]
Sper, C [1 ]
Davies, SM [1 ]
机构：
[1] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2005年 / 11卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2004.12.263
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
263
引用
收藏
页码：89 / 89
页数：1
相关论文
共 50 条
  • [31] High-dose chemotherapy decreases plasma glutathione (GSH) in patients undergoing bone marrow transplantation (BMT).
    Jonas, CR
    Puckett, AB
    Kurtz, JC
    Griffith, DP
    Newman, ML
    Furr, CE
    Galloway, JL
    Jones, DP
    Ziegler, TR
    FASEB JOURNAL, 1997, 11 (03): : 3745 - 3745
  • [32] EXPERIENCE WITH LIPOSOMAL AMPHOTERICIN-B IN 60 PATIENTS UNDERGOING HIGH-DOSE THERAPY AND BONE-MARROW OR PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION
    KRUGER, W
    STOCKSCHLADER, M
    RUSSMANN, B
    BERGER, C
    HOFFKNECHT, M
    SOBOTTKA, I
    KOHLSCHUTTER, B
    KROSCHKE, G
    KROGER, N
    HORSTMANN, M
    KABISCH, H
    ZANDER, AR
    BRITISH JOURNAL OF HAEMATOLOGY, 1995, 91 (03) : 684 - 690
  • [33] Safety, tolerance, and pharmacokinetics of a small unilamellar liposomal formulation of amphotericin B (AmBisome) in neutropenic patients
    Walsh, TJ
    Yeldandi, V
    McEvoy, M
    Gonzalez, C
    Chanock, S
    Freifeld, A
    Seibel, NI
    Whitcomb, PO
    Jarosinski, P
    Boswell, G
    Bekersky, I
    Alak, A
    Buell, D
    Barret, J
    Wilson, W
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (09) : 2391 - 2398
  • [34] Results of an open-label study of high-dose liposomal amphotericin B (AmBisome) in the treatment of confirmed fungal infections in high-risk patients
    Kinsey, S
    Jackson, G
    Holyoake, T
    McCann, S
    Gibson, B
    BRITISH JOURNAL OF HAEMATOLOGY, 2004, 125 : 62 - 63
  • [35] Pseudohyperphosphatemia associated with high-dose liposomal amphotericin B therapy
    Lane, Jason W.
    Rehak, Nadja N.
    Hortin, Glen L.
    Zaoutis, Theoklis
    Krause, Philip R.
    Walsh, Thomas J.
    CLINICA CHIMICA ACTA, 2008, 387 (1-2) : 145 - 149
  • [36] Pseudohypophosphatemia associated with high-dose liposomal amphotericin B therapy
    Mays, James A.
    Greene, Dina N.
    Poon, Anne
    Merrill, Anna E.
    CLINICAL BIOCHEMISTRY, 2017, 50 (16-17) : 967 - 971
  • [37] An open-label study of high-dose liposomal amphotericin B (AmBisome®) in the treatment of proven and probable invasive fungal infections
    Kinsey, S
    Jackson, G
    McCann, S
    Holyoake, T
    Gibson, B
    Parker, A
    Cook, G
    Jones, B
    Taylor, P
    Waters, F
    BONE MARROW TRANSPLANTATION, 2005, 35 : S178 - S179
  • [38] Nebulized Liposomal Amphotericin B Prophylaxis for Aspergillus Infection in Lung Transplantation: Pharmacokinetics and Safety
    Monforte, Victor
    Ussetti, Piedad
    Lopez, Rosa
    Gavalda, Joan
    Bravo, Carles
    de Pablo, Alicia
    Pou, Leonor
    Pahissa, Albert
    Morell, Ferran
    Roman, Antonio
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2009, 28 (02): : 170 - 175
  • [39] Amphotericin B-lipid complex (ABLC) for antifungal prophylaxis in patients receiving high-dose steroids for GVHD.
    Abbott, BL
    Kaiser, J
    Madinger, N
    Bearman, S
    McSweeney, P
    Nieto, Y
    BLOOD, 2003, 102 (11) : 431B - 431B
  • [40] Population pharmacokinetics of liposomal amphotericin B in pediatric patients with malignant diseases
    Hong, Y
    Shaw, PJ
    Nath, CE
    Yadav, SP
    Stephen, KR
    Earl, JW
    McLachlan, AJ
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (03) : 935 - 942
12345